According to Zhitong Finance App, Kangzhi Pharmaceutical (300086.SZ) issued an announcement. Today, the company received the “Notice of Case Filing” (ID: Securities Regulatory Commission No. 0292026003) issued by the China Securities Regulatory Commission (hereinafter referred to as the “China Securities Regulatory Commission”). The China Securities Regulatory Commission decided to file a case against the company in accordance with laws and regulations such as the “Securities Law of the People's Republic of China” and “Administrative Penalty Law of the People's Republic of China” due to the company's suspected illegal disclosure of information.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.